View Using Pubmed, Embase and Cochrane Database of Systematic Reviews to Identify Relevant Cases and Draw Conclusions with Regards to Their Management
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Laparoscopic Organopexy with Non-Mesh Genital (LONG)
www.nature.com/scientificreports OPEN Laparoscopic Organopexy with Non-mesh Genital (LONG) Suspension: A Novel Uterine Received: 14 November 2017 Accepted: 19 February 2018 Preservation Procedure for the Published: xx xx xxxx Treatment of Apical Prolapse Cheng-Yu Long1,2,3, Chiu-Lin Wang2,3, Chin-Ru Ker1, Yung-Shun Juan4, Eing-Mei Tsai1,3 & Kun-Ling Lin 1,3 To assess whether our novel uterus-sparing procedure- laparoscopic organopexy with non-mesh genital(LONG) suspension is an efective, safe, and timesaving surgery for the treatment of apical prolapse. Forty consecutive women with main uterine prolapse stage II or greater defned by the POP quantifcation(POP-Q) staging system were referred for LONG procedures at our hospitals. Clinical evaluations before and 6 months after surgery included pelvic examination, urodynamic study, and a personal interview to evaluate urinary and sexual symptoms with overactive bladder symptom score(OABSS), the short forms of Urogenital Distress Inventory(UDI-6) and Incontinence Impact Questionnaire(IIQ-7), and the Female Sexual Function Index(FSFI). After follow-up time of 12 to 30 months, anatomical cure rate was 85%(34/40), and the success rates for apical, anterior, and posterior vaginal prolapse were 95%(38/40), 85%(34/40), and 97.5%(39/40), respectively. Six recurrences of anterior vaginal wall all sufered from signifcant cystocele (stage3; Ba>+1) preoperatively. The average operative time was 73.1 ± 30.8 minutes. One bladder injury occurred and was recognized during surgery. The dyspareunia domain and total FSFI scores of the twelve sexually-active premenopausal women improved postoperatively in a signifcant manner (P < 0.05). -
Successful Uterovaginal Anastomosis in an Unusual Presentation Of
JSAFOMS Successful Uterovaginal Anastomosis in an Unusual Presentation10.5005/jp-journals-10032-1056 of Congenital Absence of Cervix CASE REPORT Successful Uterovaginal Anastomosis in an Unusual Presentation of Congenital Absence of Cervix 1Nusrat Mahmud, 2Naushaba Tarannum Mahtab, 3TA Chowdhury, 4Anjan Kumar Deb ABSTRACT Source of support: Nil Cervical agenesis or dysgenesis (fragmentation, fibrous cord Conflict of interest: None and obstruction) is an extremely rare congenital anomaly. Conser vative surgical approach to these patients involves uterovaginal anastomosis, cervical canalization and cervical INTRODUCTION reconstruction. In failed conservative surgery, total hysterec- Primary amenorrhea is defined as absence of menstrua- tomy is the treatment of choice. We report what we believe to be the first successful end-to-end uterovaginal anastomosis of tion by the age of 14 years in the absence of secondary an unusual case of congenital cervical agenesis. A 25-year- sex characteristics or the absence of periods by the age of old female presented complaining of primary amenorrhea 16 years regardless of appearance of secondary sex and primary subfertility for the same duration. At laparoscopy, complete separation between the cervix and the body of the charac ters. In our last study, a series of total 108 cases uterus was found and hanging from surrounding supports. of primary amenorrhea were reviewed. It was found Both ovaries and fallopian tubes were anatomically positioned. that 69.4% were due Müllerian dysgenesis, 19.4% due to There was another muscular tissue of 2 cm in diameter at the gonadal dysgenesis, 2.7% male pseudohermaphroditism pouch of Douglas which was attached with lateral pelvic wall 13 by transverse cervical ligament. -
Chapter 14 – Female Reproductive Organs
Chapter 14 – Female reproductive organs The fee allowance for a hysteroscopy procedure includes an amount for dilation and curettage (D&C) and the insertion of a Mirena coil so we will not reimburse additional fees charged for these procedures. Similarly, where a therapeutic hysteroscopy is carried out, we will not pay any additional fees charged for a diagnostic hysteroscopy. The fee allowance for a hysterectomy procedure for ovarian malignancy includes an amount for the removal of the omentum and so this should not be charged as an additional procedure. A cystoscopy should not be charged as an additional procedure alongside any suspension/uro-gynaecological procedure. The insertion of a suprapubic catheter is considered part and parcel of procedures such as a suprapubic sling or the retropubic suspension of the bladder neck and so we will not pay any additional fees charged for this procedure. The fee allowance for a colposcopy procedure includes an amount for a punch biopsy. The fee allowance for a therapeutic laparoscopy includes an amount for a diagnostic laparoscopy. The code for the insertion of a prosthesis into the ureter is intended for use by urologists inserting a stent and not for circumstances where the ureter is being identified during hysterectomy. However, we recognise this does involve some additional work and consider a small uplift in the fee to be reasonable. Many pathological processes result in the formation of adhesions so ‘adhesiolysis’ is considered to be a normal part and parcel of these procedures. Therefore, we do not have a specific code for the division of adhesions. -
To Repair Uterine Prolapse
IP 372/2 [IPGXXX] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse Uterine prolapse happens when the womb (uterus) slips down from its usual position into the vagina. Uterine suspension using mesh involves attaching 1 end of the mesh to the lower part of the uterus or cervix. The other end is attached to a bone at the base of the spine or to a ligament in the pelvis. The procedure can be done through open abdominal surgery or laparoscopy (keyhole surgery). The aim is to support the womb. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this interventional procedure (IP) overview to help members of the interventional procedures advisory committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This IP overview was prepared in January 2016. Procedure name Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse. Specialist societies Royal College of Obstetricians and Gynaecologists (RCOG) British Society of Urogynaecology (BSUG) British Association of Urological Surgeons (BAUS). IP overview: Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse. Page 1 of 75 IP 372/2 [IPGXXX] Description Indications and current treatment Uterine prolapse is when the uterus descends from its usual position, into and sometimes through, the vagina. It can affect quality of life by causing symptoms of pressure and discomfort, and by its effects on urinary, bowel and sexual function. -
Septate Uterus As Congenital Uterine Anomaly: a Case Report
em & yst Se S xu e a v l i t D c i s u o Reproductive System & Sexual Moghadam et al., Reprod Syst Sex Disord 2014, 3:4 d r o d r e p r e DOI: 10.4172/2161-038X.1000141 s R ISSN: 2161-038X Disorders: Current Research Case Report Open Access Septate Uterus as Congenital Uterine Anomaly: A Case Report Abas Heidari Moghadam1,2, Zahra Jozi1, Shapoor Dahaz1 and DarioushBijan Nejad1* 1Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS), Ahvaz, Iran 2Diagnostic Imaging Center of Ahvaz Oil Grand Hospital, Ahvaz, Iran *Correspondingauthor: Darioush Bijan Nejad, Assistant Professor, Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences (AJUMS), Ahvaz, Iran, Tel: +98 918 343 4253; Fax: +98 611 333 6380; E-mail:[email protected] Received: June 14, 2014; Accepted: August 01, 2014; Published: August 08, 2014 Copyright: © 2013 Moghadam AH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Abnormal fusion of Mullerian duct in embryonic life is the origin of variety of malformations which may alter the reproductive outcome of the patients. Septate uterus is caused by incomplete resorption of the Mullerian duct during embryogenesis. Here, we report a case of septate uterus that was initially diagnosed by ultrasound scan and confirmed by Magnetic Resonance Imaging (MRI) technique. Keywords: Septate uterus; Mullarian ducts; Ultrasound; MRI Case Report A 29 year old lady came to the imaging diagnostic center of Ahvaz Introduction Oil Grand Hospital. -
Female Infertility: Ultrasound and Hysterosalpoingography
s z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 11, Issue, 01, pp.745-754, January, 2019 DOI: https://doi.org/10.24941/ijcr.34061.01.2019 ISSN: 0975-833X RESEARCH ARTICLE FEMALE INFERTILITY: ULTRASOUND AND HYSTEROSALPOINGOGRAPHY 1*Dr. Muna Mahmood Daood, 2Dr. Khawla Natheer Hameed Al Tawel and 3 Dr. Noor Al _Huda Abd Jarjees 1Radiologist Specialist, Ibin Al Atheer hospital, Mosul, Iraq 2Lecturer Radiologist Specialist, Institue of radiology, Mosul, Iraq 3Radiologist Specialist, Ibin Al Atheer Hospital, Mosu, Iraq ARTICLE INFO ABSTRACT Article History: The causes of female infertility are multifactorial and necessitate comprehensive evaluation including Received 09th October, 2018 physical examination, hormonal testing, and imaging. Given the associated psychological and Received in revised form th financial stress that imaging can cause, infertility patients benefit from a structured and streamlined 26 November, 2018 evaluation. The goal of such a work up is to evaluate the uterus, endometrium, and fallopian tubes for Accepted 04th December, 2018 anomalies or abnormalities potentially preventing normal conception. Published online 31st January, 2019 Key Words: WHO: World Health Organization, HSG, Hysterosalpingography, US: Ultrasound PID: pelvic Inflammatory Disease, IV: Intravenous. OHSS: Ovarian Hyper Stimulation Syndrome. Copyright © 2019, Muna Mahmood Daood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Dr. Muna Mahmood Daood, Dr. Khawla Natheer Hameed Al Tawel and Dr. Noor Al _Huda Abd Jarjees. 2019. “Female infertility: ultrasound and hysterosalpoingography”, International Journal of Current Research, 11, (01), 745-754. -
Abdominal Sacrohysteropexy Versus Vaginal Hysterectomy for Pelvic Organ Prolapse in Young Women
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Bhalerao AV et al. Int J Reprod Contracept Obstet Gynecol. 2020 Apr;9(4):1434-1441 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20201201 Original Research Article Abdominal sacrohysteropexy versus vaginal hysterectomy for pelvic organ prolapse in young women Anuja V. Bhalerao, Vaidehi A. Duddalwar* Department of Obstetrics and Gynecology, N. K. P. Salve Institute of Medical Sciences, Nagpur, Maharashtra, India Received: 11 February 2020 Accepted: 03 March 2020 *Correspondence: Dr. Vaidehi A. Duddalwar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Pelvic organ prolapse (POP) is the descent of the pelvic organs beyond their anatomical confines. The definitive treatment of symptomatic prolapse is surgery but its management in young is unique due to various considerations. Aim of this study was to evaluate anatomical and functional outcome after abdominal sacrohysteropexy and vaginal hysterectomy for pelvic organ prolapse in young women. Methods: A total 27 women less than 35 years of age with pelvic organ prolapse underwent either abdominal sacrohysteropexy or vaginal hysterectomy with repair. In all women, pre-op and post-op POP-Q was done for evaluation of anatomical defect and a validated questionnaire was given for subjective outcome. Results: Anatomical outcome was significant in both groups as per POP-Q grading but the symptomatic outcome was better for sacrohysteropexy with regard to surgical time, bleeding, ovarian conservation, urinary symptoms, sexual function. -
Sacrohysteropexy for Uterine Prolapse (Womb Prolapse)
Sacrohysteropexy for Uterine Prolapse (Womb Prolapse) Patient Information Leaflet About this leaflet You should use the information provided in this leaflet as a guide. The way each gynaecologist does this procedure may vary slightly as will care in the hospital after your procedure and the advice given to you when you get home. You should ask your gynaecologist about any concerns that you may have. You should take your time to read this leaflet. A page is provided at the end of the leaflet for you to write down any questions you may have. It is your right to know about your planned operation or procedure, why it has been recommended, what the alternatives are and what the risks and benefits are. These should be covered in this leaflet. You may also want to ask about your gynaecologist’s experience and results of treating your condition. Benefits and risks There are not many studies about the success and the risks of most of the procedures carried out to treat prolapse and incontinence, so it is often difficult to state them clearly. In this leaflet, we may refer to risks as common, rare and so on, or we may give an approximate level of risk. You can find more information about risk in a leaflet ‘Understanding how risk is discussed in healthcare’ published by the Royal College of Obstetricians and Gynaecologists. https://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pi- understanding-risk.pdf The following table is taken from that leaflet British Society of Urogynaecology (BSUG) database To understand the success and risks of surgery for prolapse and incontinence the British Society of Urogynaecology has set up a national database. -
Management of Reproductive Tract Anomalies
The Journal of Obstetrics and Gynecology of India (May–June 2017) 67(3):162–167 DOI 10.1007/s13224-017-1001-8 INVITED MINI REVIEW Management of Reproductive Tract Anomalies 1 1 Garima Kachhawa • Alka Kriplani Received: 29 March 2017 / Accepted: 21 April 2017 / Published online: 2 May 2017 Ó Federation of Obstetric & Gynecological Societies of India 2017 About the Author Dr. Garima Kachhawa is a consultant Obstetrician and Gynaecologist in Delhi since over 15 years; at present, she is working as faculty at the premiere institute of India, prestigious All India Institute of Medical Sciences, New Delhi. She has several publications in various national and international journals to her credit. She has been awarded various national awards, including Dr. Siuli Rudra Sinha Prize by FOGSI and AV Gandhi award for best research in endocrinology. Her field of interest is endoscopy and reproductive and adolescent endocrinology. She has served as the Joint Secretary of FOGSI in 2016–2017. Abstract Reproductive tract malformations are rare in problems depend on the anatomic distortions, which may general population but are commonly encountered in range from congenital absence of the vagina to complex women with infertility and recurrent pregnancy loss. defects in the lateral and vertical fusion of the Mu¨llerian Obstructive anomalies present around menarche causing duct system. Identification of symptoms and timely diag- extreme pain and adversely affecting the life of the young nosis are an important key to the management of these women. The clinical signs, symptoms and reproductive defects. Although MRI being gold standard in delineating uterine anatomy, recent advances in imaging technology, specifically 3-dimensional ultrasound, achieve accurate Dr. -
Midwifery & Women's Health Nurse Practitioner Certification Review
MIDWIFERY & WOMEN’S HEALTH NURSE PRACTITIONER CERTIFICATION REVIEW GUIDE Second Edition Edited by Beth M. Kelsey, EdD, WHNP-BC Assistant Professor School of Nursing Ball State University Muncie, Indiana Board of Directors National Association of Nurse Practitioners in Women’s Health (NPWH) Washington, DC 74172_FMXx_ttlpg.indd 1 7/30/10 2:53 PM World Headquarters Jones & Bartlett Learning Jones & Bartlett Learning Jones and Bartlett Learning 40 Tall Pine Drive Canada International Sudbury, MA 01776 6339 Ormindale Way Barb House, Barb Mews 978-443-5000 Mississauga, Ontario L5V 1J2 London W6 7PA [email protected] Canada United Kingdom www.jblearning.com Jones & Bartlett Learning books and products are available through most bookstores and online booksellers. To contact Jones & Bartlett Learning directly, call 800-832-0034, fax 978-443-8000, or visit our website, www.jblearning.com. Substantial discounts on bulk quantities of Jones & Bartlett Learning publications are available to corporations, professional associations, and other qualified organizations. For details and specific discount information, contact the special sales department at Jones & Bartlett Learning via the above contact information or send an email to [email protected]. Copyright © 2011 by Jones & Bartlett Learning, LLC All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission from the copyright owner. The authors, editor, and publisher have made every effort to provide accurate information. However, they are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of the products and procedures described. -
6Th I-DSD Symposium Programme. 29Th June – 1St July 2017, Copenhagen, Denmark
6th I-DSD Symposium Programme. 29th June – 1st July 2017, Copenhagen, Denmark Abstracts Session 1 – Setting The Scene “Stuck in the middle” Eric Vilain MD PhD For families, the birth of a child with a Disorder/Difference of Sex Development (DSD), and uncertainty about the child’s gender and future psychosocial development, is believed to be very stressful. Potential stressors include the parents’ need to gather medical information, make decisions about gender assignment and surgical interventions, cope with medical treatments and the possibility of multiple operations, and handle familial strains related to the perceived stigma of DSD. These stressors are amplified by a large number of uncertainties in the management of DSD. I will review the current uncertainties in the world of DSD (naming, diagnosis, gender, genital surgery, disclosure, fertility, outcomes) and discuss how I have attempted to navigate the waters –often troubled- flowing between the different stakeholders involved with DSD. Session 2 – International Collaborations & Moving Forward The needs of people with conditions affecting sex development Joanne Hall (CLIMB CAH Group) Joanne is a mother of two daughters with salt wasting Congenital Adrenal Hyperplasia and is a member of the UK based CAH support group. Joanne represents the support group at European COST Action meetings and through this recently co-ordinated a European based patient/parent workshop, primarily to engage with professionals and discuss what has worked and has not worked with patient care from childhood through to adulthood. Using learning from this workshop, along with her personal and professional experience of working with families and facilitating groups, Joanne hopes to provide information and practical guidance for professionals to engage with parents and patients, in order to find out what the needs are for people affected by conditions of sexual development within the professional’s own local clinical setting. -
Icd-9-Cm (2010)
ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular